Tailored breast cancer screening based on personal risk
Part of Cancer, Skin clinical trials.
This trial looks at a new way to tailor breast cancer screening using your personal risk and additional imaging. It may help find cancer earlier, especially for women at higher risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a woman aged 40 to 74.
- Get breast cancer screening at Södersjukhuset in Stockholm.
- Have a smartphone or tablet with BankID.
- Not be pregnant, breastfeeding, or planning to become pregnant.
- Have no previous breast cancer diagnosis.
- Be able to understand the study and undergo a contrast mammogram (or have an alternative if not possible).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to make breast cancer screening more personal. It may help if you have very dense breast tissue or if you had a false alarm (a positive result that turned out to be no cancer). The study compares different screening approaches to see which works best for women like you.
This study uses a smartphone app and biological markers to predict cancer risk. It is testing whether digital and molecular data can help identify cancer earlier, especially in women with a history of certain cancers.
This trial tests whether radiation therapy can be personalized based on your risk of the cancer coming back and your risk of side effects from radiation. Depending on those factors, you may receive a tailored radiation plan that could be more or less intense.
This trial tests a program to help people at high risk for certain cancers get the free screening tests they need. It aims to make screening easier by providing personalized guidance in the community.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
This study tests a more thorough breast cancer screening program using MRI and other imaging for women at high risk. It aims to detect cancer earlier, which may improve treatment options and outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.